Therefore, in order to understand the exact clinical characteristics and prognosis of single HR-positive breast cancer (ER + PR- tumors and ER-PR+ tumors), we compared these tumors to double HR+ tumors as well as HR- tumors (ER-PR-), and stratified these results according to HER2 overexpression. Here, ESR1 is linked to breast carcinoma.